EPAS1 and nonpapillary renal cell carcinoma: In contrast to HIF2A inactivation (Extended Data Fig. 5b), PAX8 inhibition compromised ccRCC proliferation in vitro (Extended Data Fig. 1b), which indicated the presence of HIF2A-independent oncogenic PAX8 functions.